Viewing nowCombinationNewstatin T.S. Tablet 80/5/10 Milligrams
Telmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.

MFDS item code 201802237 · Approved 2018.05.30 · Insurance code 647804700
Treatment of dyslipidemia and hypertension, inhibition of the progression of atherosclerosis, and prevention of cardiovascular disease
This medication is used only in patients with essential hypertension whose blood pressure is not adequately controlled with either telmisartan or amlodipine alone and in cases where rosuvastatin needs to be administered simultaneously. The telmisartan/amlodipine combination effectively controls and stabilizes blood pressure. Rosuvastatin calcium improves lipid disorders such as hypercholesterolemia and is used as an adjunct to diet when not controlled by diet and exercise. This medication also helps slow the progression of atherosclerosis and reduce the risk of stroke, myocardial infarction, and revascularization in patients at risk for cardiovascular disease by controlling both blood pressure and cholesterol simultaneously, thus effectively improving cardiovascular health.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take it at the same time every day (e.g., in the morning). This medicine should be administered only to adults. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking the telmisartan/amlodipine combination together with rosuvastatin as a single agent, they may switch to this medicine (a combination tablet containing the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the dose of each individual ingredient (amlodipine or telmisartan) be adjusted. However, if blood pressure is not controlled with the individual ingredients as described below, switching directly to the telmisartan/amlodipine combination may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased up to a maximum of 20 mg per day. 2. Older patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but exposure increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. In a drug interaction study of telmisartan/amlodipine 80/10mg and rosuvastatin 20mg, the active ingredients of this medicine, the Cmax of rosuvastatin increased by approximately 2.1-fold and its AUC increased by approximately 1.2-fold in the presence of telmisartan/amlodipine. Therefore, when administering this medicine, the potential risks associated with the increase in rosuvastatin Cmax should be assessed, and patients should be monitored closely.
This medication should not be used during pregnancy as it may cause serious harm to the fetus and newborn. If pregnancy is confirmed, discontinuation should occur immediately. Do not take this medication if you are allergic to any of its ingredients or have certain genetic diseases, severe liver or kidney diseases. Particularly, patients with a history of angioedema, severe aortic stenosis, myopathy, and severe renal impairment should not take this medication. Patients with hypertension, decreased liver function, elderly patients, and those with hyperkalemia should use this medication cautiously and monitor liver function tests and muscle-related tests periodically. If symptoms such as muscle pain or weakness appear, consult a doctor immediately and discontinue if necessary. This medication may interact with various other drugs, so inform your healthcare provider of any other medications you are taking. Women of childbearing potential should use appropriate contraception and it is recommended not to use this medication while breastfeeding. Safety and efficacy have not been well established for children under 18 years of age; therefore, it is not recommended. For elderly patients, especially those over 75 years old, it is advisable to start with a lower dose and gradually increase. In cases of overdose, symptoms such as low blood pressure, dizziness, and cardiac abnormalities may occur, so visit a medical institution immediately. Keep this medication out of the reach of children and do not transfer it to another container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in an opaque container that does not allow light to enter. Additionally, it is important to store the medication at room temperature, between 1 degree and 30 degrees Celsius, to maintain its effectiveness.
Oval-shaped bilayer tablet consisting of a white layer and a light blue layer
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.